Our results indicate that 213Bi-C595 is effective for pancreatic cancer spheroids up to 100 μm in diameter, and that targeting efficacy is in accordance with the expression of MUC1 in three cancer cell lines. Here, MUC1 is linked to familial pancreatic carcinoma.